InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
| NSPR Stock | USD 2.77 0.06 2.21% |
Slightly above 55% of InspireMD's retail investors are presently thinking to get in. The analysis of overall sentiment of trading InspireMD stock suggests that some investors are interested at this time. InspireMD's investing sentiment overview a quick insight into current market opportunities from investing in InspireMD. Many technical investors use InspireMD stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
InspireMD |
-Conference call and webcast to be held at 830 a.m. EDT-TEL AVIV, Israel and MIAMI, May 07, 2024 -- InspireMD, Inc. , developer of the CGuard Embolic Prevention Stent System device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open. Management will host a conference call and webcast with the investment community at 830
Read at finance.yahoo.com
 |
InspireMD Fundamental Analysis
We analyze InspireMD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InspireMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InspireMD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
InspireMD is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
InspireMD Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InspireMD stock to make a market-neutral strategy. Peer analysis of InspireMD could also be used in its relative valuation, which is a method of valuing InspireMD by comparing valuation metrics with similar companies.
Peers
InspireMD Related Equities
| SSKN | STRATA Skin | 0.99 | ||||
| RPID | Rapid Micro | 0.97 | ||||
| VVOS | Vivos Therapeutics | 0.46 | ||||
| SGHT | Sight Sciences | 0.30 | ||||
| SRDX | SurModics | 0.05 | ||||
| IRIX | IRIDEX | 1.11 | ||||
| RSLS | ReShape Lifesciences | 3.07 | ||||
| NPCE | Neuropace | 3.30 | ||||
| LNSR | LENSAR | 3.47 | ||||
| NUWE | Nuwellis | 3.60 | ||||
| TIVC | Tivic Health | 6.45 | ||||
| BBLG | Bone Biologics | 8.18 | ||||
| BJDX | Bluejay Diagnostics | 8.83 | ||||
| TNON | Tenon Medical | 12.32 | ||||
| AIMD | Ainos | 13.64 |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.